Latest Tags

Involving Users in Developing Health Information

We are pleased to inform you of our involvement in the upcoming Patient Information Forum (PIF) event on ‘Involving Users in Developing Health Information’, which will take place on Wednesday 17th May 2017 in London. The event offers health information professionals the chance to network with other delegates whilst providing practical case studies and learning opportunities. […]

Read more

TOPRA launches new Product Information special interest group

Luto’s co-founder and academic advisor, Professor Theo Raynor recently became a member of the newly formed TOPRA group on Product Information launched in November 2016 at a meeting at their office in London, pictured right.  The group will: provide opportunities to share regulatory knowledge relating to product information across the drug product life cycle via TOPRA, collectively voice […]

Read more

Luto newsletter – How clear is your health information?

Luto now provides an even stronger service offering so we’ve put together our first newsletter as a way to tell people about our latest developments. In this first edition, we include a case study on our project with Macmillan Cancer Support, to review and refine the charity’s cancer information booklets. We also welcome Steven our new […]

Read more

‘It’s all there in black and white’ – or is it? Improving medicines labelling

Research on the labelling of over-the-counter medicines has been published in the international journal ‘Health Expectations’ with the support of Luto. This is the work of PhD candidate Vivien Tong from the University of Sydney – with one of the co-authors being Professor Theo Raynor, co-founder and academic advisor to Luto. The paper described preliminary […]

Read more

Luto awards winning poster to BHF – Empowering people through film

The PiF conference was a pleasure to attend as usual – enthusiastic speakers and equally enthusiastic delegates. Early on Sue Farringdon mentioned the NHS ‘Five Year Forward View’ and this made me reflect on my personal ’35 Year Backward View’ – of the amazing development of the field of patient information during my professional life. […]

Read more

Join Luto at the DIA Annual Euromeeting and Clinical Forum this April

Luto will be exhibiting at the DIA Annual EuroMeeting and Clinical Forum in Paris from 13th to 15th April. The team will be delighted to welcome new and existing customers to our stand on Level 2 of the Exhibition Hall – Stand 2.D21. Professor Theo Raynor, Co-founder and Academic Advisor to Luto will be joining […]

Read more

The Health Literacy Group UK one day seminar

In the 10 years since Luto was founded, the profile of Health Literacy as a health service priority has grown and grown. Making health information materials more accessible and understandable is at the heart of Luto’s work, and at this seminar in Leeds, Theo Raynor the company’s co-founder and academic advisor, will use better information […]

Read more

Luto founder given a lifetime achievement award

Professor Theo Raynor, who co-founded Luto research in 2004 and continues to play a large role in the company as academic advisor, was given a Lifetime Achievement Award by the Royal Pharmaceutical Society at a recent ceremony at the Birmingham International Convention Centre. The nomination records that Theo has pioneered innovative, patient centered research in […]

Read more

Risk Management Plan Lay Summary User Testing presented in London

Professor Theo Raynor, co-founder and academic advisor to Luto recently presented preliminary results of the user testing of Risk Management Plan (RMP) lay summaries at the DIA 8th European Medical Information and Communications conference. This was part of a session he had helped organise called “Information to patients in the European Union”. The session was […]

Read more

Risk Management Plan lay summaries – are they fit for purpose?

Luto co-founder and academic advisor, Professor Theo Raynor had the opportunity to present his thoughts on the new Risk Management Plan lay summaries at two recent DIA events; the Annual Euro Meeting in Vienna and the European Forum for QPPV in London. In Vienna, Theo gave a ‘temperature check’ on the lay summaries, based on […]

Read more

Luto supports NHS England workshop on medicines taking

Patients and carers recruited by Luto played a key role in a recent workshop ‘Making medicines‑taking a better experience’. They featured in the report of the workshop on the NHS England website which is available to read here. There were 5 key themes generated by the patients and carers during the workshop, including the provision of better […]

Read more

Luto facilitates future development of over-the-counter medicines information

During the summer of 2013, Luto had the pleasure of welcoming Vivien Tong, a PhD candidate from the Faculty of Pharmacy at The University of Sydney into our company. In a collaboration brought about by the Worldwide Universities Network (WUN), Vivien is jointly supervised by Associate Professor Parisa Aslani (The University of Sydney) and Professor […]

Read more

Patient information leaflets – Clarkson shares his thoughts

Jeremy Clarkson has taken a pop at patient information leaflets in The Sun newspaper. He has a point, writes Professor Theo Raynor, and pharmacists must not be complacent about their usefulness. Clarkson’s piece was headed “Warned off pill popping”, and referred to a patient information leaflet his mother had been given. The language used, such as describing […]

Read more

Professor Theo Raynor invited to give the Rennebohm Lectures in USA

Professor Theo Raynor has been invited to give the prestigious Rennebohm Lectures at the University of Wisconsin at Madison, in November this year. The lectures have been running since 1955, when they were established by Oscar Rennebohm, a pharmacist who served as State Governor in the 1940s and established a foundation at the University. This […]

Read more

European Public Assessment Report (EPAR) summaries for the public: are they fit for purpose? A user-testing study

Making European Public Assessment Reports (EPARs) accessible to the public through a summary is a great idea and the EMA should be applauded for the initiative. This research shows however that formatting and content could be improved through ‘user testing’ with members of the public – a process which pharma companies and others now routinely […]

Read more